The Drugs Controller General of India (DCGI) has approved the market authorisation of Serum Institute of India’s (SII) COVID-19 vaccine Covovax as a heterologous booster dose. This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin. Earlier, the DCGI approved Covovax for […]
Read Time : 2 Minutes
DGCI grants conditional market approval for Covaxin, Covishield
The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population. According to Union Health Ministry, the vaccines will not be available in medical stores. The hospitals and clinics can now […]